Quetiapine Fumarate Patent Expiration

Quetiapine Fumarate is Used for treating major depressive disorder (MDD) and schizophrenia. It was first introduced by Astrazeneca Pharmaceuticals Lp in its drug Seroquel on Sep 26, 1997. Another drug containing Quetiapine Fumarate is Seroquel Xr. 30 different companies have introduced drugs containing Quetiapine Fumarate.


Quetiapine Fumarate Patents

Given below is the list of patents protecting Quetiapine Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Seroquel Xr US5948437

(Pediatric)

Pharmaceutical compositions using thiazepine Nov 28, 2017

(Expired)

Astrazeneca
Seroquel Xr US5948437 Pharmaceutical compositions using thiazepine May 28, 2017

(Expired)

Astrazeneca



Quetiapine Fumarate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Quetiapine Fumarate Generic API Manufacturers

Several generic applications have been filed for Quetiapine Fumarate. The first generic version for Quetiapine Fumarate was by Teva Pharmaceuticals Usa and was approved on Mar 27, 2012. And the latest generic version is by Graviti Pharmaceuticals Private Ltd and was approved on Nov 26, 2024.

Given below is the list of companies who have filed for Quetiapine Fumarate generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017
EQ 300MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Nov 1, 2016
EQ 150MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017





2. ACTAVIS GRP PTC

Actavis Group Ptc Ehf has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Actavis Grp Ptc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013
EQ 50MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013
EQ 100MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013
EQ 150MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013
EQ 200MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013
EQ 300MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013
EQ 400MG BASE

tablet Discontinued ORAL N/A Feb 27, 2013





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE

tablet Discontinued ORAL N/A Oct 28, 2014
EQ 25MG BASE

tablet Discontinued ORAL N/A Oct 28, 2014
EQ 50MG BASE

tablet Discontinued ORAL N/A Oct 28, 2014
EQ 100MG BASE

tablet Discontinued ORAL N/A Oct 28, 2014
EQ 200MG BASE

tablet Discontinued ORAL N/A Oct 28, 2014
EQ 400MG BASE

tablet Discontinued ORAL N/A Oct 28, 2014


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)





4. ALIGNSCIENCE PHARMA

Alignscience Pharma Inc has filed for 2 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alignscience Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2018
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Sep 28, 2018





5. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Feb 12, 2013
EQ 50MG BASE

tablet Prescription ORAL AB Feb 12, 2013
EQ 100MG BASE

tablet Prescription ORAL AB Feb 12, 2013
EQ 150MG BASE

tablet Prescription ORAL AB Feb 12, 2013
EQ 200MG BASE

tablet Prescription ORAL AB Feb 12, 2013
EQ 300MG BASE

tablet Prescription ORAL AB Feb 12, 2013
EQ 400MG BASE

tablet Prescription ORAL AB Feb 12, 2013





6. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE

tablet, extended release Discontinued ORAL N/A Oct 26, 2018





7. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 300MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





8. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE

tablet Prescription ORAL AB Mar 27, 2012


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





9. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012
EQ 400MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012
EQ 300MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012
EQ 200MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012
EQ 25MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012
EQ 150MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012
EQ 100MG BASE

tablet Discontinued ORAL N/A Dec 14, 2012





10. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE

tablet Prescription ORAL AB Mar 27, 2012





11. ENDO OPERATIONS

Endo Operations Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE

tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 200MG BASE

tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 150MG BASE

tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 50MG BASE

tablet, extended release Discontinued ORAL N/A May 9, 2017
EQ 300MG BASE

tablet, extended release Discontinued ORAL N/A Dec 1, 2017





12. GRAVITI PHARMS

Graviti Pharmaceuticals Private Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Graviti Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Nov 26, 2024
EQ 300MG BASE

tablet, extended release Prescription ORAL AB Nov 26, 2024
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Nov 26, 2024
EQ 50MG BASE

tablet, extended release Prescription ORAL AB Nov 26, 2024
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Nov 26, 2024





13. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Jun 16, 2022
EQ 300MG BASE

tablet Prescription ORAL AB Jun 16, 2022
EQ 400MG BASE

tablet Prescription ORAL AB Jun 16, 2022
EQ 25MG BASE

tablet Prescription ORAL AB Jun 16, 2022
EQ 200MG BASE

tablet Prescription ORAL AB Jun 16, 2022
EQ 100MG BASE

tablet Prescription ORAL AB Jun 16, 2022





14. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE

tablet Prescription ORAL AB Mar 27, 2012


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





15. INTELLIPHARMACEUTICS

Intellipharmaceutics Corp has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Intellipharmaceutics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017
EQ 200MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017
EQ 300MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017
EQ 50MG BASE

tablet, extended release Prescription ORAL AB May 9, 2017


Manufacturing Plant Locations
New

Intellipharmaceutics's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Intellipharmaceutics as present at those locations.

Country City Firm Name
Canada
Etobicoke IntelliPharmaCeutics Corp.





16. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE

tablet Prescription ORAL AB May 20, 2024
EQ 400MG BASE

tablet Prescription ORAL AB May 20, 2024
EQ 25MG BASE

tablet Prescription ORAL AB May 20, 2024
EQ 50MG BASE

tablet Prescription ORAL AB May 20, 2024
EQ 100MG BASE

tablet Prescription ORAL AB May 20, 2024
EQ 200MG BASE

tablet Prescription ORAL AB May 20, 2024





17. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Nov 26, 2013


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





18. LUPIN LTD

Lupin Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet, extended release Prescription ORAL AB May 17, 2017
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet, extended release Prescription ORAL AB May 17, 2017
EQ 300MG BASE

tablet, extended release Prescription ORAL AB May 17, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB May 17, 2017
EQ 150MG BASE

tablet, extended release Prescription ORAL AB May 17, 2017


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





19. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB May 17, 2016
EQ 300MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 50MG BASE

tablet Prescription ORAL AB May 17, 2016
EQ 25MG BASE

tablet Prescription ORAL AB May 17, 2016
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017





20. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012





21. NOVAST LABS

Novast Laboratories Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 50MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 300MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017





22. PHARMADAX INC

Pharmadax Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Pharmadax Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet, extended release Discontinued ORAL N/A May 9, 2017
EQ 150MG BASE

tablet, extended release Discontinued ORAL N/A May 9, 2017
EQ 400MG BASE

tablet, extended release Discontinued ORAL N/A May 9, 2017
EQ 200MG BASE

tablet, extended release Discontinued ORAL N/A May 9, 2017
EQ 300MG BASE

tablet, extended release Discontinued ORAL N/A May 9, 2017


Manufacturing Plant Locations
New

Pharmadax Inc's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Pharmadax Inc as present at those locations.

Country City Firm Name
Taiwan
New Taipei City Pharmadax Inc.





23. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Aug 24, 2022
EQ 300MG BASE

tablet Prescription ORAL AB Aug 24, 2022
EQ 200MG BASE

tablet Prescription ORAL AB Aug 24, 2022
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Apr 26, 2022
EQ 100MG BASE

tablet Prescription ORAL AB Aug 24, 2022
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Mar 11, 2024
EQ 25MG BASE

tablet Prescription ORAL AB Aug 24, 2022





24. RISING

Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 300MG BASE

tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 400MG BASE

tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 150MG BASE

tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 50MG BASE

tablet, extended release Discontinued ORAL N/A Feb 2, 2021


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Fort Bragg Rising Tide Sea Vegetables
Saddle Brook Rising Pharmaceuticals, Inc.
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
East Brunswick Rising Pharma Holding, Inc.
Mount Morris Rising Creek Bakery LLC
Rising Sun Rising Sun Veterinary Clinic
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





25. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet, extended release Prescription ORAL AB Nov 16, 2018
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 300MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Nov 29, 2017





26. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE

tablet Prescription ORAL AB Mar 27, 2012


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
India
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra Sun Pharmaceutical Industries Limited
Baruch Sun Pharmaceutical Industries Ltd.





27. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 25MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE

tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE

tablet Prescription ORAL AB Mar 27, 2012





28. TORRENT PHARMS LTD

Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012
EQ 50MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012
EQ 100MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012
EQ 200MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012
EQ 300MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012
EQ 400MG BASE

tablet Discontinued ORAL N/A Mar 27, 2012





29. UNICHEM

Unichem Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 25MG BASE

tablet Prescription ORAL AB Mar 8, 2016
EQ 100MG BASE

tablet Prescription ORAL AB Mar 8, 2016
EQ 200MG BASE

tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 300MG BASE

tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 400MG BASE

tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Aug 15, 2022


Manufacturing Plant Locations
New

Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.

Country City Firm Name
India
Ghaziabad Unichem Laboratories Ltd.
Mumbai Unichem Laboratories Limited
Kolhapur Unichem Laboratories Limited
Pilerne Bardez Unichem Laboratories Limited
Pithampur Unichem Laboratories Limited
District Raigad Unichem Laboratories Ltd
United States
Hasbrouck Heights Unichem Pharmaceuticals Usa Inc
East Brunswick Unichem Pharmaceuticals USA Inc.